Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-01 Sale(A) |
2023-09-06 7:10 pm |
EyePoint Pharmaceuticals Inc. | EYPT | EW Healthcare Partners L.P. EW Healthcare Partners-A L.P. Essex Woodlands Fund IX-GP L.P. Essex Woodlands IX LLC See footnotes 1 and 3 10% Owner |
20,000 | $9.8991 | $197,982 | 3,490,921 (Indirect) |
View |
| 2023-09-01 Sale |
2023-09-06 5:14 pm |
EyePoint Pharmaceuticals Inc. | EYPT | EW Healthcare Partners L.P. EW Healthcare Partners-A L.P. Essex Woodlands Fund IX-GP L.P. Essex Woodlands IX LLC See footnotes 1 and 3 10% Owner |
20,000 | $9.8991 | $197,982 | 3,490,921 (Indirect) |
View |
| 2023-08-30 Sale |
2023-09-01 4:51 pm |
EyePoint Pharmaceuticals Inc. | EYPT | EW Healthcare Partners L.P. EW Healthcare Partners-A L.P. Essex Woodlands Fund IX-GP L.P. Essex Woodlands IX LLC See footnotes 1 and 6 10% Owner |
139,471 | $10.54 | $1,470,208 | 3,510,921 (Indirect) |
View |
| 2023-08-28 Sale |
2023-08-30 5:46 pm |
EyePoint Pharmaceuticals Inc. | EYPT | EW Healthcare Partners L.P. EW Healthcare Partners-A L.P. Essex Woodlands Fund IX-GP L.P. Essex Woodlands IX LLC See footnotes 1 and 4 10% Owner |
148,712 | $11.14 | $1,656,878 | 3,650,392 (Indirect) |
View |
| 2023-08-24 Sale(A) |
2023-08-30 5:32 pm |
EyePoint Pharmaceuticals Inc. | EYPT | EW Healthcare Partners L.P. EW Healthcare Partners-A L.P. Essex Woodlands Fund IX-GP L.P. Essex Woodlands IX LLC See footnotes 1 and 6 10% Owner |
223,936 | $11.11 | $2,487,482 | 3,799,104 (Indirect) |
View |
| 2023-08-24 Sale |
2023-08-28 6:32 pm |
EyePoint Pharmaceuticals Inc. | EYPT | EW Healthcare Partners L.P. EW Healthcare Partners-A L.P. Essex Woodlands Fund IX-GP L.P. Essex Woodlands IX LLC See footnotes 1 and 2 10% Owner |
223,936 | $13.25 | $2,967,572 | 3,799,104 (Indirect) |
View |
| 2023-08-22 Sale |
2023-08-24 5:30 pm |
EyePoint Pharmaceuticals Inc. | EYPT | EW Healthcare Partners L.P. EW Healthcare Partners-A L.P. Essex Woodlands Fund IX-GP L.P. Essex Woodlands IX LLC See footnotes 1 and 2 10% Owner |
167,881 | $13.49 | $2,264,748 | 4,023,040 (Indirect) |
View |
| 2023-05-30 Sale |
2023-05-31 5:22 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Liu Ye Director |
1 | $6 | $6 | 3,010,721 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2023-12-06 4:38 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Chen Bihua 10% Owner |
0 | $0 | 3,530,943 (Indirect) |
View |
| 2023-10-16 Option Award |
2023-10-17 4:49 pm |
N/A 2033-10-15 |
EyePoint Pharmaceuticals Inc. | EYPT | Duty Stuart Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2023-10-16 Option Award |
2023-10-17 4:47 pm |
N/A 2033-10-15 |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-07-10 Option Award |
2023-07-12 6:53 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-07-10 Option Award |
2023-07-12 6:52 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-07-11 Exercise |
2023-07-12 6:51 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director |
2,000 | $0 | 6,000 (Direct) |
View |
| 2023-06-23 Exercise |
2023-06-26 5:10 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | ADAMIS ANTHONY P Director |
2,000 | $0 | 6,000 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:22 am |
2024-01-06 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
39,100 | $0 | 39,100 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:21 am |
2024-01-06 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
39,100 | $0 | 39,100 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:19 am |
2024-01-06 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | DICICCO WENDY F Director |
39,100 | $0 | 39,100 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:19 am |
2024-01-06 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | ANDO GORAN Director |
40,600 | $0 | 40,600 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:18 am |
2024-01-06 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | ADAMIS ANTHONY P Director |
39,100 | $0 | 39,100 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:18 am |
2024-01-06 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director |
39,100 | $0 | 39,100 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:16 am |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Pine Michael Craig Chief Corp Dev.&Strat. Officer |
45,855 | $0 | 45,855 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:16 am |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
45,855 | $0 | 45,855 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:15 am |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
45,855 | $0 | 45,855 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:15 am |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
45,855 | $0 | 45,855 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:14 am |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO |
225,400 | $0 | 225,400 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:13 am |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and COO |
62,380 | $0 | 62,380 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:14 pm |
N/A 2033-05-24 |
EyePoint Pharmaceuticals Inc. | EYPT | Pine Michael Craig Chief Corp Dev.&Strat. Officer |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:13 pm |
N/A 2033-05-24 |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
67,500 | $0 | 67,500 (Direct) |
View |
| 2023-05-11 Gift |
2023-05-15 6:15 pm |
N/A 2026-09-15 |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO |
771,088 | $0 | 784,500 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 5:08 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
3,000 | $0 | 7,400 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 5:07 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
10,800 | $0 | 42,341 (Direct) |
View |
| 2023-02-09 Tax Withholding |
2023-02-13 5:07 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
3,744 | $4.17 | 42,341 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 5:06 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | DICICCO WENDY F Director |
3,000 | $0 | 7,400 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 5:05 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
3,000 | $0 | 11,400 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 5:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | ANDO GORAN Director |
3,250 | $0 | 8,150 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 5:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and COO |
11,967 | $0 | 48,188 (Direct) |
View |
| 2023-02-09 Tax Withholding |
2023-02-13 5:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and COO |
4,148 | $4.17 | 48,188 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 5:02 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
9,967 | $0 | 40,100 (Direct) |
View |
| 2023-02-09 Tax Withholding |
2023-02-13 5:02 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
2,956 | $4.17 | 40,100 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 4:58 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
10,800 | $0 | 39,750 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 4:56 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO |
37,533 | $0 | 248,093 (Direct) |
View |